Research Topics
| Ioannis KioumisSummaryAffiliation: University of Athens Country: Greece Publications
| Collaborators
|
Detail Information
Publications
Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniaePaschalina Kontou
Division of Pulmonary Critical Care, G Papanikolaou Hospital, Thessaloniki, Greece
Am J Emerg Med 27:968-74. 2009..In this study, the 2007 Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) consensus criteria for ICU admission were compared with other severity scores in predicting ICU admission and mortality...
Pharmacokinetics of ciprofloxacin and its penetration into bronchial secretions of mechanically ventilated patients with chronic obstructive pulmonary diseasePaschalina Kontou
A Intensive Care Unit, G Papanikolaou Hospital, Exohi, Thessaloniki 57010, Greece
Antimicrob Agents Chemother 55:4149-53. 2011..There is wide interindividual variability in its pharmacokinetic parameters in critically ill COPD patients and inadequate pharmacodynamic exposure against bacteria with MICs of ≥0.5 μg/ml...
Sarcoidosis-associated pulmonary hypertension: a role for endothelin receptor antagonists?Georgia G Pitsiou
Respiratory Failure Unit, G Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
Ther Adv Respir Dis 3:99-101. 2009..Addition of bosentan, a dual endothelin receptor antagonist, resulted in marked improvement in functional class and exercise capacity of the patient, allowing gradual tapering of steroids...
Lemierre's syndrome presenting to the ED: rapidly fatal sepsis caused by methicillin-susceptible Staphylococcus aureus Staphylococcus protein A type t044Georgia Pitsiou
Respiratory Failure Unit, Aristotle University of Thessaloniki, G H G Papanikolaou, Exohi, Thessaloniki, 57010, Greece
Am J Emerg Med 31:268.e5-7. 2013..Recognition of such virulent community-acquired strains is of great importance because they could prove to be emerging pathogens for life-threatening diseases...
